The small number of PALB2 mutations limits interpretation; however, RAD51C, RAD51D, and BRIP1 mutations were associated with both high rates of biallelic loss and high GIS, suggesting that these genes might be true drivers of HRD in ovarian cancer. This evidence concerns the gene PALB2 and ovarian cancer.